These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26409505)

  • 21. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of immunosenescence on transplant outcome.
    Heinbokel T; Hock K; Liu G; Edtinger K; Elkhal A; Tullius SG
    Transpl Int; 2013 Mar; 26(3):242-53. PubMed ID: 23190423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of recipient age on the clinical course of renal transplantation].
    Palomar R; Ruiz JC; Cotorruelo JG; Zubimendi JA; de Francisco AL; Rodrigo E; Sanz S; Arias M
    Nefrologia; 2001; 21(4):386-91. PubMed ID: 11816515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Older donors and older recipients in kidney transplantation.
    Stallone G; Infante B; Gesualdo L
    J Nephrol; 2010; 23 Suppl 15():S98-103. PubMed ID: 20872377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New paradigms in immunosuppression.
    Huizinga R; Voyer T
    CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients.
    Badowski M; Gurk-Turner C; Cangro C; Weir M; Philosophe B; Klassen D; Haririan A
    Clin Transplant; 2009; 23(6):930-7. PubMed ID: 19594773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney and liver transplantation in the elderly.
    Sutherland AI; IJzermans JN; Forsythe JL; Dor FJ
    Br J Surg; 2016 Jan; 103(2):e62-72. PubMed ID: 26662845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal transplant allocation criteria, desensitization strategies and immunosuppressive therapy in retransplant renal patients.
    Salvadori M; Bertoni E
    J Nephrol; 2012; 25(6):890-9. PubMed ID: 22972671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial.
    Malat GE; Ranganna KM; Sikalas N; Liu L; Jindal RM; Doyle A
    Transplantation; 2012 Nov; 94(10):1020-4. PubMed ID: 23169224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Present state of immunosuppressive therapy in liver transplant recipients.
    Wiesner RH; Fung JJ
    Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transplantation at the University of Pittsburgh.
    Shapiro R; Sturdevant M; Lopez R; Tan H; Basu A; Wijkstrom M; Humar A
    Clin Transpl; 2011; ():67-76. PubMed ID: 22755403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized immunosuppression in elderly renal transplant recipients.
    Peeters LEJ; Andrews LM; Hesselink DA; de Winter BCM; van Gelder T
    Pharmacol Res; 2018 Apr; 130():303-307. PubMed ID: 29501679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toward individualized immunosuppression].
    Grinyó JM
    Nefrologia; 2001; 21(3):232. PubMed ID: 11471302
    [No Abstract]   [Full Text] [Related]  

  • 35. Transplantation: new protocols and new worries.
    Grinyo JM
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of immunosuppressive minimization and tolerance strategies.
    Brouard S; Budde K
    Transpl Int; 2015 Aug; 28(8):889-90. PubMed ID: 26178312
    [No Abstract]   [Full Text] [Related]  

  • 37. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
    Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
    Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
    Rodríguez Ferrero M; Valderrábano F
    Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
    [No Abstract]   [Full Text] [Related]  

  • 39. Corticosteroid elimination in simultaneous liver-kidney transplantation recipients.
    Weber NK; Wiseman AC; Trotter JF
    Clin Transplant; 2009; 23(6):958-63. PubMed ID: 19664017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney Transplant Program at the Mayo Clinic in Arizona.
    Heilman RL; Khamash HA; Huskey JL; Chakkera HA; Batra RK; Katariya NN; Singer AL; Mathur AK; Moss AA; Reddy KS
    Clin Transpl; 2014; ():61-8. PubMed ID: 26281128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.